SC
ABBV icon

Sapient Capital’s AbbVie ABBV Stock Holding History

Sapient Capital’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q3 		$55M Buy
210,256
+14,020
+7% +$3.59M 0.74% 21
2026
Q2 		$49.4M Sell
196,236
-8,705
-4% -$1.87M 0.65% 22
2026
Q1 		$44.6M Sell
204,941
-15,994
-7% -$3.55M 0.67% 24
2025
Q4 		$50.7M Buy
220,935
+984
+0.4% +$224K 0.71% 22
2025
Q3 		$49.1M Sell
219,951
-8,543
-4% -$1.74M 0.76% 22
2025
Q2 		$42.4M Sell
228,494
-1,594
-0.7% -$296K 0.76% 27
2025
Q1 		$48.2M Sell
230,088
-28,811
-11% -$5.6M 0.95% 20
2024
Q4 		$46M Buy
258,899
+3,404
+1% +$626K 0.88% 21
2024
Q3 		$50.5M Buy
255,495
+6,258
+3% +$1.17M 1.01% 18
2024
Q2 		$42.7M Sell
249,237
-18,767
-7% -$3.11M 0.89% 20
2024
Q1 		$48.8M Sell
268,004
-55,328
-17% -$9.54M 1.08% 18
2023
Q4 		$50.1M Buy
+323,332
New +$47.1M 1.29% 14

Other funds holding ABBV

HCM
Hamlin Capital Management New York $4.04B AUM 11.59% 1-Year Est. Return
FWCM
Ferguson Wellman Capital Management Portland, Oregon $8.38B AUM 25.07% 1-Year Est. Return
MSV
MN Services Vermogensbeheer The Hague, Netherlands $13.4B AUM 37.34% 1-Year Est. Return
AIM
Artemis Investment Management Edinburgh, United Kingdom $11.5B AUM 61.77% 1-Year Est. Return
EB
Eastern Bank Boston, Massachusetts $6.58B AUM 23.57% 1-Year Est. Return
AP
Atwood & Palmer Kansas City, Missouri $1.95B AUM 16% 1-Year Est. Return
MPWT
MassMutual Private Wealth & Trust Windsor, Connecticut $3.79B AUM 19.33% 1-Year Est. Return
FFA
Farther Finance Advisors San Francisco, California $14.2B AUM 18.33% 1-Year Est. Return
VCM
Violich Capital Management San Francisco, California $927M AUM 28.93% 1-Year Est. Return
PNC
Park National Corp Newark, Ohio $3.69B AUM 18.32% 1-Year Est. Return

Sapient Capital's ABBV Position: Q3 2026 in Review

Sapient Capital increased its AbbVie (ABBV) stake by 7.1% in Q3 2026, buying an estimated $3.59M and bringing the position to 210,256 shares worth $55M. The position accounts for 0.74% of the portfolio, ranked #21.

Sapient Capital first reported a position in ABBV in Q4 2023 and has held it in 12 quarters since. 165 funds tracked by Wall St. Rank hold ABBV as of Q3 2026.

  • Sapient Capital held 210,256 shares of AbbVie worth $55M as of Q3 2026.
  • Sapient Capital bought 14,020 AbbVie shares in Q3 2026, an estimated $3.59M.
  • AbbVie made up 0.74% of Sapient Capital's portfolio in Q3 2026, its #21 holding.
  • Sapient Capital first reported a position in AbbVie in Q4 2023 and has held it in 12 quarters since.
  • 165 funds tracked by Wall St. Rank held AbbVie as of Q3 2026.

Based on Sapient Capital's 13F filing for Q3 2026, filed 8 Oct 2026.